Skip to content
  • People
  • Pipeline
  • Publications
  • News
  • Blogs
  • People
  • Pipeline
  • Publications
  • News
  • Blogs
  • People
  • Pipeline
  • Publications
  • News
  • Blogs
  • Contact us
  • People
  • Pipeline
  • Publications
  • News
  • Blogs
  • Contact us
Contact

Post-Covid-19 cognitive impairment: a new target for drug development?

April 25, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne, and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment.

Click here to read the article online
Alternatively, click here to download the PDF

PrevOlder
NewerNext

Bringing Precision Medicine to Neuroscience Drug Development

MT LOGO WHITE PNG-01
info@monumenttx.com
Get in touch
© Copyright 2026  |  Privacy Policy & Terms of Use